H&T Presspart, the world’s leading manufacturer of components for respiratory drug delivery systems are pleased to announce they will be presenting at this year’s Digitalization in Pharma Summit, held in Prague from 15-16 March.

Dr Benjamin Jung, H&T Presspart Program Manager, will be delivering a speech entitled ‘Embedded connected metered-dose inhalers meeting requirements for mass adoption’. The speech will discuss how non-adherence to medication is a critical problem for chronic diseases, especially in association with Asthma and COPD.

Dr Jung will present how connected drug delivery systems can help track patient adherence, engage patients to take ownership of their own care, and connect patients to their providers and other stakeholders in real time.

Finally Dr Jung will discuss the various requirements for the mass adoption of these systems and how they can be addressed with embedded solutions.

During his speech, Dr Jung will directly reference as a case study H&T Presspart’s own smart connected inhaler, the eMDITM , which has been developed in partnership with Cohero Health TM, as the first market-ready, fully embedded and connected metered-dose inhaler.

The Digitalization in Pharma Summit will bring together Digital innovation and business strategy experts in Pharma to ensure maximum knowledge transfer and professional exchange. They will elaborate on the best practices within the industry as well as academia and therewith learn about the latest trends on digitalization in improving end user experience.